Your browser doesn't support javascript.
loading
Genome-scale functional genomics identify genes preferentially essential for multiple myeloma cells compared to other neoplasias.
de Matos Simoes, Ricardo; Shirasaki, Ryosuke; Downey-Kopyscinski, Sondra L; Matthews, Geoffrey M; Barwick, Benjamin G; Gupta, Vikas A; Dupéré-Richer, Daphné; Yamano, Shizuka; Hu, Yiguo; Sheffer, Michal; Dhimolea, Eugen; Dashevsky, Olga; Gandolfi, Sara; Ishiguro, Kazuya; Meyers, Robin M; Bryan, Jordan G; Dharia, Neekesh V; Hengeveld, Paul J; Brüggenthies, Johanna B; Tang, Huihui; Aguirre, Andrew J; Sievers, Quinlan L; Ebert, Benjamin L; Glassner, Brian J; Ott, Christopher J; Bradner, James E; Kwiatkowski, Nicholas P; Auclair, Daniel; Levy, Joan; Keats, Jonathan J; Groen, Richard W J; Gray, Nathanael S; Culhane, Aedin C; McFarland, James M; Dempster, Joshua M; Licht, Jonathan D; Boise, Lawrence H; Hahn, William C; Vazquez, Francisca; Tsherniak, Aviad; Mitsiades, Constantine S.
  • de Matos Simoes R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Shirasaki R; Harvard Medical School, Boston, MA, USA.
  • Downey-Kopyscinski SL; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.
  • Matthews GM; Ludwig Center at Harvard, Boston, MA, USA.
  • Barwick BG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Gupta VA; Harvard Medical School, Boston, MA, USA.
  • Dupéré-Richer D; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.
  • Yamano S; Ludwig Center at Harvard, Boston, MA, USA.
  • Hu Y; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Sheffer M; Harvard Medical School, Boston, MA, USA.
  • Dhimolea E; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.
  • Dashevsky O; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Gandolfi S; Harvard Medical School, Boston, MA, USA.
  • Ishiguro K; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.
  • Meyers RM; Department of Hematology and Medical Oncology and the Winship Cancer Institute, Emory University, Atlanta, GA, USA.
  • Bryan JG; Department of Hematology and Medical Oncology and the Winship Cancer Institute, Emory University, Atlanta, GA, USA.
  • Dharia NV; University of Florida Health Cancer Center, Gainesville, FL, USA.
  • Hengeveld PJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Brüggenthies JB; Harvard Medical School, Boston, MA, USA.
  • Tang H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Aguirre AJ; Harvard Medical School, Boston, MA, USA.
  • Sievers QL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Ebert BL; Harvard Medical School, Boston, MA, USA.
  • Glassner BJ; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.
  • Ott CJ; Ludwig Center at Harvard, Boston, MA, USA.
  • Bradner JE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Kwiatkowski NP; Harvard Medical School, Boston, MA, USA.
  • Auclair D; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.
  • Levy J; Ludwig Center at Harvard, Boston, MA, USA.
  • Keats JJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Groen RWJ; Harvard Medical School, Boston, MA, USA.
  • Gray NS; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.
  • Culhane AC; Ludwig Center at Harvard, Boston, MA, USA.
  • McFarland JM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Dempster JM; Harvard Medical School, Boston, MA, USA.
  • Licht JD; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.
  • Boise LH; Ludwig Center at Harvard, Boston, MA, USA.
  • Hahn WC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Vazquez F; Harvard Medical School, Boston, MA, USA.
  • Tsherniak A; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.
  • Mitsiades CS; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.
Nat Cancer ; 4(5): 754-773, 2023 05.
Article en En | MEDLINE | ID: mdl-37237081
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Mieloma Múltiple Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Mieloma Múltiple Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article